Concepts for selection and utilization of psychiatric medications in pregnancy.
| Autor: | Vickery PB |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The mental health clinician [Ment Health Clin] 2023 Dec 01; Vol. 13 (6), pp. 255-267. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2023). |
| DOI: | 10.9740/mhc.2023.12.255 |
| Abstrakt: | Psychiatric illness may develop or relapse during pregnancy, and understanding best practices is paramount. In 2017, the British Association for Psychopharmacology (BAP) consensus guidance on the use of psychotropic medication preconception, in pregnancy, and postpartum was released. The BAP guidelines provide concise evidence and additional insight and flexibility for use of psychiatric medication. Key takeaways of these guidelines are highlighted serving as a concise reference for practitioners. Additionally, practice points, such as recommendations for rapid tranquilization and the role of long-acting injectable antipsychotic medications as well as additional insights to the growing body of literature associated with psychiatric medications in pregnancy since 2017 are summarized. Providers are strongly encouraged to stay up to date to provide optimal care for pregnant patients and their babies. Competing Interests: Disclosures: Psychopharmacology Pearls are review articles intended to highlight both the evidence base available and/or controversial areas of clinical care for psychiatric, neurologic, and substance use disorder conditions as well as strategies of clinical decision-making used by expert clinicians. As pearls, articles reflect the views and practice of each author as substantiated with evidence-based facts as well as opinion and experience. All patient cases in this article represent scenarios that may be encountered in practice but are illustrative or educational in nature. Articles are edited by members of the Psychopharmacology Pearls Editorial Board as well as peer reviewed by MHC reviewers. This article was developed as part of the 2023 Psychopharmacology Pearls product for BCPP recertification credit. The course information and testing center is at https://aapp.org/549207. (© 2023 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|